2021-2030 Report on Global Disease Risk and Health DNA Test Market by Player, Region, Type, Application and Sales Channel

2021-2030 Report on Global Disease Risk and Health DNA Test Market by Player, Region, Type, Application and Sales Channel

Report Code: KNJ1010543 | No. of Pages: 133 | Category: Telecom and IT
Publisher: MAResearch | Date of Publish: Nov-2021
This report studies the Disease Risk and Health DNA Test market, covering market size for segment by type (Celiac Disease, Parkinson Disease, etc.), by application (Online Test, Offline Test, etc.), by sales channel (Direct Channel, Distribution Channel), by player (23andMe, MyHeritage, LabCorp, Myriad Genetics, Ancestry.com, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa).

This report provides detailed historical analysis of global market for Disease Risk and Health DNA Test from 2015-2020, and provides extensive market forecasts from 2021-2030 by region/country and subsectors. It covers the sales/revenue/value, gross margin, historical growth and future perspectives in the Disease Risk and Health DNA Test market.

Moreover, the impact of COVID-19 is also concerned. Since outbreak in December 2019, the COVID-19 virus has spread to all around the world and caused huge losses of lives and economy, and the global manufacturing, tourism and financial markets have been hit hard, while the online market/industry increase. Fortunately, with the development of vaccine and other effort by global governments and organizations, the negative impact of COVID-19 is expected to subside and the global economy is expected to recover.

This research covers COVID-19 impacts on the upstream, midstream and downstream industries. Moreover, this research provides an in-depth market evaluation by highlighting information on various aspects covering market dynamics like drivers, barriers, opportunities, threats, and industry news & trends. In the end, this report also provides in-depth analysis and professional advices on how to face the post COIVD-19 period.

The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.

Leading players of Disease Risk and Health DNA Test including:
    23andMe
    MyHeritage
    LabCorp
    Myriad Genetics
    Ancestry.com
    Quest Diagnostics
    Gene By Gene
    DNA Diagnostics Center
    Invitae
    IntelliGenetics
    Ambry Genetics
    Living DNA
    EasyDNA
    Pathway Genomics
    Centrillion Technology
    Xcode
    Color Genomics
    Anglia DNA Services
    African Ancestry
    Canadian DNA Services
    DNA Family Check
    Alpha Biolaboratories
    Test Me DNA
    23 Mofang
    Genetic Health
    DNA Services of America
    Shuwen Health Sciences
    Mapmygenome
    Full Genomes

Market split by Type, can be divided into:
    Celiac Disease
    Parkinson Disease
    Alzheimer Disease
    Other

Market split by Application, can be divided into:
    Online Test
    Offline Test

Market split by Sales Channel, can be divided into:
    Direct Channel
    Distribution Channel

Market segment by Region/Country including:
    North America (United States, Canada and Mexico)
    Europe (Germany, UK, France, Italy, Russia and Spain etc.)
    Asia-Pacific (China, Japan, Korea, India, Australia and Southeast Asia etc.)
    South America (Brazil, Argentina and Colombia etc.)
    Middle East & Africa (South Africa, UAE and Saudi Arabia etc.)

If you have any special requirements, please let us know and we can provide you the customized report as you want.

Table of Contents

Chapter 1 Disease Risk and Health DNA Test Market Overview
    1.1 Disease Risk and Health DNA Test Definition
    1.2 Global Disease Risk and Health DNA Test Market Size Status and Outlook (2015-2030)
    1.3 Global Disease Risk and Health DNA Test Market Size Comparison by Region (2015-2030)
    1.4 Global Disease Risk and Health DNA Test Market Size Comparison by Type (2015-2030)
    1.5 Global Disease Risk and Health DNA Test Market Size Comparison by Application (2015-2030)
    1.6 Global Disease Risk and Health DNA Test Market Size Comparison by Sales Channel (2015-2030)
    1.7 Disease Risk and Health DNA Test Market Dynamics (COVID-19 Impacts)
        1.7.1 Market Drivers/Opportunities
        1.7.2 Market Challenges/Risks
        1.7.3 Market News (Mergers/Acquisitions/Expansion)
        1.7.4 COVID-19 Impacts on Current Market
        1.7.5 Post-Strategies of COVID-19 Outbreak
Chapter 2 Disease Risk and Health DNA Test Market Segment Analysis by Player
    2.1 Global Disease Risk and Health DNA Test Sales and Market Share by Player (2018-2020)
    2.2 Global Disease Risk and Health DNA Test Revenue and Market Share by Player (2018-2020)
    2.3 Global Disease Risk and Health DNA Test Average Price by Player (2018-2020)
    2.4 Players Competition Situation & Trends
    2.5 Conclusion of Segment by Player
Chapter 3 Disease Risk and Health DNA Test Market Segment Analysis by Type
    3.1 Global Disease Risk and Health DNA Test Market by Type
        3.1.1 Celiac Disease
        3.1.2 Parkinson Disease
        3.1.3 Alzheimer Disease
        3.1.4 Other
    3.2 Global Disease Risk and Health DNA Test Sales and Market Share by Type (2015-2020)
    3.3 Global Disease Risk and Health DNA Test Revenue and Market Share by Type (2015-2020)
    3.4 Global Disease Risk and Health DNA Test Average Price by Type (2015-2020)
    3.5 Leading Players of Disease Risk and Health DNA Test by Type in 2020
    3.6 Conclusion of Segment by Type
Chapter 4 Disease Risk and Health DNA Test Market Segment Analysis by Application
    4.1 Global Disease Risk and Health DNA Test Market by Application
        4.1.1 Online Test
        4.1.2 Offline Test
    4.2 Global Disease Risk and Health DNA Test Revenue and Market Share by Application (2015-2020)
    4.3 Leading Consumers of Disease Risk and Health DNA Test by Application in 2020
    4.4 Conclusion of Segment by Application
Chapter 5 Disease Risk and Health DNA Test Market Segment Analysis by Sales Channel
    5.1 Global Disease Risk and Health DNA Test Market by Sales Channel
        5.1.1 Direct Channel
        5.1.2 Distribution Channel
    5.2 Global Disease Risk and Health DNA Test Revenue and Market Share by Sales Channel (2015-2020)
    5.3 Leading Distributors/Dealers of Disease Risk and Health DNA Test by Sales Channel in 2020
    5.4 Conclusion of Segment by Sales Channel
Chapter 6 Disease Risk and Health DNA Test Market Segment Analysis by Region
    6.1 Global Disease Risk and Health DNA Test Market Size and CAGR by Region (2015-2030)
    6.2 Global Disease Risk and Health DNA Test Sales and Market Share by Region (2015-2020)
    6.3 Global Disease Risk and Health DNA Test Revenue and Market Share by Region (2015-2020)
    6.4 North America
        6.4.1 North America Market by Country
        6.4.2 North America Disease Risk and Health DNA Test Market Share by Type
        6.4.3 North America Disease Risk and Health DNA Test Market Share by Application
        6.4.4 United States
        6.4.5 Canada
        6.4.6 Mexico
    6.5 Europe
        6.5.1 Europe Market by Country
        6.5.2 Europe Disease Risk and Health DNA Test Market Share by Type
        6.5.3 Europe Disease Risk and Health DNA Test Market Share by Application
        6.5.4 Germany
        6.5.5 UK
        6.5.6 France
        6.5.7 Italy
        6.5.8 Russia
        6.5.9 Spain
    6.6 Asia-Pacific
        6.6.1 Asia-Pacific Market by Country
        6.6.2 Asia-Pacific Disease Risk and Health DNA Test Market Share by Type
        6.6.3 Asia-Pacific Disease Risk and Health DNA Test Market Share by Application
        6.6.4 China
        6.6.5 Japan
        6.6.6 Korea
        6.6.7 India
        6.6.8 Southeast Asia
        6.6.9 Australia
    6.7 South America
        6.7.1 South America Market by Country
        6.7.2 South America Disease Risk and Health DNA Test Market Share by Type
        6.7.3 South America Disease Risk and Health DNA Test Market Share by Application
        6.7.4 Brazil
        6.7.5 Argentina
        6.7.6 Colombia
    6.8 Middle East & Africa
        6.8.1 Middle East & Africa Market by Country
        6.8.2 Middle East & Africa Disease Risk and Health DNA Test Market Share by Type
        6.8.3 Middle East & Africa Disease Risk and Health DNA Test Market Share by Application
        6.8.4 UAE
        6.8.5 Saudi Arabia
        6.8.6 South Africa
    6.9 Conclusion of Segment by Region
Chapter 7 Profile of Leading Disease Risk and Health DNA Test Players
    7.1 23andMe
        7.1.1 Company Snapshot
        7.1.2 Product/Service Offered
        7.1.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
        7.1.4 COVID-19 Impact on 23andMe
    7.2 MyHeritage
    7.3 LabCorp
    7.4 Myriad Genetics
    7.5 Ancestry.com
    7.6 Quest Diagnostics
    7.7 Gene By Gene
    7.8 DNA Diagnostics Center
    7.9 Invitae
    7.10 IntelliGenetics
    7.11 Ambry Genetics
    7.12 Living DNA
    7.13 EasyDNA
    7.14 Pathway Genomics
    7.15 Centrillion Technology
    7.16 Xcode
    7.17 Color Genomics
    7.18 Anglia DNA Services
    7.19 African Ancestry
    7.20 Canadian DNA Services
    7.21 DNA Family Check
    7.22 Alpha Biolaboratories
    7.23 Test Me DNA
    7.24 23 Mofang
    7.25 Genetic Health
    7.26 DNA Services of America
    7.27 Shuwen Health Sciences
    7.28 Mapmygenome
    7.29 Full Genomes
    7.29 Full Genomes
Chapter 8 Upstream and Downstream Analysis of Disease Risk and Health DNA Test
    8.1 Industrial Chain of Disease Risk and Health DNA Test
    8.2 Upstream of Disease Risk and Health DNA Test
        8.2.1 Raw Materials
        8.2.2 Labor Cost
        8.2.3 Manufacturing Expenses
        8.2.4 Manufacturing Cost Structure
        8.2.5 Manufacturing Process
    8.3 Downstream of Disease Risk and Health DNA Test
        8.3.1 Leading Distributors/Dealers of Disease Risk and Health DNA Test
        8.3.2 Leading Consumers of Disease Risk and Health DNA Test
Chapter 9 Development Trend of Disease Risk and Health DNA Test (2021-2030)
    9.1 Global Disease Risk and Health DNA Test Market Size (Sales and Revenue) Forecast (2021-2030)
    9.2 Global Disease Risk and Health DNA Test Market Size and CAGR Forecast by Region (2021-2030)
    9.3 Global Disease Risk and Health DNA Test Market Size and CAGR Forecast by Type (2021-2030)
    9.4 Global Disease Risk and Health DNA Test Market Size and CAGR Forecast by Application (2021-2030)
    9.5 Global Disease Risk and Health DNA Test Market Size and CAGR Forecast by Sales Channel (2021-2030)
Chapter 10 Appendix
    10.1 Research Methodology
    10.2 Data Sources
    10.3 Disclaimer
    10.4 Analysts Certification


NEED Help?

If you need any help or guidance, please feel free to call us.

USA : +1 (661) 636 6162

INDIA : +91 9325802062

or

Write us on : sales@kandjmarketresearch.com